Search Results - "Conter, Henry J"

A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre by Cheema, Parneet K, Iafolla, Marco A J, Nematollahi, Massey, Berco, FeRevelyn, Kaushik, Deepanjali, Matthews, Priscilla, Raskin, William R, Perdrizet, Kirstin A, Dudani, Shaan, Husain, Juhi, Balcewicz, Margaret, Kuruvilla, Philip G, Reingold, Stephen M, Conter, Henry J

“…The increased use of immune checkpoint inhibitors across cancer programs has created the need for standardized patient assessment, education, monitoring, and…”
Get full text

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial by West, Howard, McCleod, Michael, Hussein, Maen, Morabito, Alessandro, Rittmeyer, Achim, Conter, Henry J, Kopp, Hans-Georg, Daniel, Davey, McCune, Steven, Mekhail, Tarek, Zer, Alona, Reinmuth, Niels, Sadiq, Ahad, Sandler, Alan, Lin, Wei, Ochi Lohmann, Tania, Archer, Venice, Wang, Lijia, Kowanetz, Marcin, Cappuzzo, Federico

“…Atezolizumab (a monoclonal antibody against PD-L1), which restores anticancer immunity, improved overall survival in patients with previously treated…”
Get full text

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial by Jotte, Robert, Cappuzzo, Federico, Vynnychenko, Ihor, Stroyakovskiy, Daniil, Rodríguez-Abreu, Delvys, Hussein, Maen, Soo, Ross, Conter, Henry J, Kozuki, Toshiyuki, Huang, Kuan-Chieh, Graupner, Vilma, Sun, Shawn W, Hoang, Tien, Jessop, Helen, McCleland, Mark, Ballinger, Marcus, Sandler, Alan, Socinski, Mark A

“…Cytotoxic agents have immunomodulatory effects, providing a rationale for combining atezolizumab (anti-programmed death-ligand 1 [anti-PD-L1]) with…”
Get more information

Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience by Conter, Henry J., Gopalakrishnan, Vancheswaran, Ravi, Vinod, Ater, Joann L., Patel, Shreyaskumar, Araujo, Dejka M.

“…Background. Staging and treatment of adult neuroblastoma has yet to be formalized. We sought to determine the utility of the pediatric classification system in…”
Get full text

Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study by Yu, Evan Y., Kolinsky, Michael P., Berry, William R., Retz, Margitta, Mourey, Loic, Piulats, Josep M., Appleman, Leonard J., Romano, Emanuela, Gravis, Gwenaelle, Gurney, Howard, Bögemann, Martin, Emmenegger, Urban, Joshua, Anthony M., Linch, Mark, Sridhar, Srikala, Conter, Henry J., Laguerre, Brigitte, Massard, Christophe, Li, Xin Tong, Schloss, Charles, Poehlein, Christian H., de Bono, Johann S.

“…The KEYNOTE-365 study assessed the efficacy and safety of pembrolizumab combination therapies in metastatic castration-resistant prostate cancer pretreated…”
Get full text

Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysis by Farid-Kapadia, Mufiza, Barton, Madelyn, Bider-Canfield, Zoe, Cheema, Parneet K, Gyawali, Bishal, Nightingale, Natalie M, Latifovic, Lidija, Conter, Henry J

“…To examine whether tumor-specific and tumor-agnostic oncology trials produce comparable estimates of objective response rate (ORR) in -altered cancers…”
Get full text

Overlapping Systematic Reviews of Anterior Cruciate Ligament Reconstruction Comparing Hamstring Autograft with Bone-Patellar Tendon-Bone Autograft: Why Are They Different? by Poolman, Rudolf W, Abouali, Jihad A.K, Conter, Henry J, Bhandari, Mohit

“…BackgroundSystematic reviews published on the same topic during a similar period of time (i.e., overlapping reviews) on anterior cruciate ligament…”
Get full text

Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D by Yu, Evan Y., Ferrario, Cristiano, Linch, Mark D., Stoeckle, Michael, Laguerre, Brigitte, Arranz, Jose A., Todenhöfer, Tilman, Fong, Peter C., Piulats, Josep M., Berry, William, Emmenegger, Urban, Mourey, Loic, Joshua, Anthony M., Mar, Nataliya, Appleman, Leonard J., Conter, Henry J., Gravis, Gwenaelle, Li, Xin Tong, Schloss, Charles, Poehlein, Christian, de Bono, Johann S.

“…Pembrolizumab plus abiraterone and prednisone exhibited antitumor activity and acceptable safety in patients with chemotherapy-naive metastatic…”
Get full text

Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum by Saad, Fred, Canil, Christina, Finelli, Antonio, Hotte, Sebastien J, Malone, Shawn, Shayegan, Bobby, So, Alan I, Aaron, Lorne, Basappa, Naveen S, Conter, Henry J, Danielson, Brita, Gotto, Geoffrey, Hamilton, Robert J, Izard, Jason P, Kapoor, Anil, Kolinsky, Michael, Lalani, Aly-Khan A, Lattouf, Jean-Baptiste, Morash, Christopher, Morgan, Scott C, Niazi, Tamim, Noonan, Krista L, Ong, Michael, Rendon, Ricardo A, Sehdev, Sandeep, Hew, Huong, Park-Wyllie, Laura, Chi, Kim N

“…The management of advanced prostate cancer (PCa) continues to evolve with the emergence of new diagnostic and therapeutic strategies. As a result, there are…”
Get full text

Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study by Yu, Evan Y, Berry, William R, Gurney, Howard, Retz, Margitta, Conter, Henry J, Laguerre, Brigitte, Fong, Peter C C, Ferrario, Cristiano, Todenhöfer, Tilman, Gravis, Gwenaelle, Piulats, Josep M, Emmenegger, Urban, Shore, Neal D, Romano, Emanuela, Mourey, Loic, Li, Xin Tong, Poehlein, Christian H, Schloss, Charles, Appleman, Leonard J, de Bono, Johann S

“…Limited responses have been observed in patients treated with enzalutamide after disease progression on abiraterone for metastatic castration-resistant…”
Get full text

Twenty Years of Meta-Analyses in Orthopaedic Surgery: Has Quality Kept Up with Quantity? by Dijkman, Bernadette G, Abouali, Jihad A.K, Kooistra, Bauke W, Conter, Henry J, Poolman, Rudolf W, Kulkarni, Abhaya V, Tornetta, Paul, Bhandari, Mohit

“…BACKGROUND:As the number of studies in the literature is increasing, orthopaedic surgeons highly depend on meta-analyses as their primary source of scientific…”
Get full text

Management algorithms for metastatic prostate cancer by Malone, Shawn, Shayegan, Bobby, Basappa, Naveen S, Chi, Kim, Conter, Henry J, Hamilton, Robert J, Hotte, Sebastien J, Saad, Fred, So, Alan I, Park-Wyllie, Laura, Hew, Huong, McLeod, Deanna, Gotto, Geoffrey

“…Prostate cancer poses a significant lifetime risk to Canadian men. Treatment for metastatic prostatic cancer (mPCa) is an area of ongoing research with a lack…”
Get full text

Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019 by Hotte, Sebastien J., Kapoor, Anil, Basappa, Naveen S., Bjarnason, Georg, Canil, Christina, Conter, Henry J., Czaykowski, Piotr, Graham, Jeffrey, Gray, Samantha, Heng, Daniel Y. C., Karakiewicz, Pierre I., Kollmannsberger, Christian, Lalani, Aly-Khan A., North, Scott A., Patenaude, François, Soulières, Denis, Violette, Phillippe, Winquist, Eric, Wood, Lori A., Dudani, Shaan, Maloni, Ranjena, Reaume, M. Neil

Get full text

Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces by Woon, Dixon T S, Chandrasekar, Thenappan, Aaron, Lorne, Basappa, Naveen S, Chi, Kim N, Conter, Henry J, Danielson, Brita, Hotte, Sebastien J, Malone, Shawn, Saad, Fred, Shayegan, Bobby, Park-Wyllie, Laura, Hamilton, Robert J

“…Treatment using abiraterone acetate, enzalutamide, cabazitaxel, and radium-223 (Ra-223) improve overall survival (OS) and quality of life for patients with…”
Get full text

Values-based health care debate, not statistics by Conter, Henry J

“…Although the main focus of "America, embrace health care reform"1 revolves around finances, the editorial lacks 'values.' The Canadian health care plan is a…”
Get full text

Patient advocacy: health, money or both? by Conter, Henry J

“…Dr. Bouzayen, in her recent editorial calling for public funding of in vitro fertilization (IVF),1 makes a convincing argument that the current high cost of…”
Get full text

A A Canadian consensus forum on the management of patients with advanced prostate cancer by Saad, Fred, Canil, Christina, Finelli, Antonio, Hotte, Sebastien J, Malone, Shawn, Shayegan, Bobby, So, Alan I, Aaron, Lorne, Basappa, Naveen S, Conter, Henry J, Danielson, Brita, Hamilton, Robert J, Kapoor, Anil, Kolinsky, Michael, Lalani, Aly-Khan A, Lattouf, Jean-Baptiste, Morash, Christopher, Morgan, Scott C, Niazi, Tamim, Ong, Michael, Rendon, Ricardo A, Sehdev, Sandeep, Hew, Huong, Park-Wyllie, Laura, Chi, Kim N

“…Introduction: The management of advanced prostate cancer (PCa) continues to evolve with the emergence of new diagnostic and therapeutic strategies. As a…”
Get full text

Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017 by Reaume, M Neil, Basappa, Naveen S, Wood, Lori, Kapoor, Anil, Bjarnason, Georg A, Blais, Normand, Breau, Rodney H, Canil, Christina, Cheung, Patrick, Conter, Henry J, Hotte, Sebastien J, Jeldres, Claudio, Jewett, Michael A S, Karakiewicz, Pierre I, Kollmannsberger, Christian, Patenaude, Francois, So, Alan, Soulières, Denis, Venner, Peter, Violette, Phillippe, Zalewski, Pawel, Chappell, Heather, North, Scott A

“…N/A…”
Get full text

Curability of Poor-Risk Metastatic Sarcomatoid Renal Cell Carcinoma with the Combination of Gemcitabine, 5-Fluorouracil, and Interferon-Alfa: A Case Report of a 55-Year-Old Man with a 10-Year Complete Remission by Conter, Henry J, Lim, Zita D, Ng, Chaan S, Millikan, Randall E, Tannir, Nizar M

Get full text

Overlapping Systematic Reviews of Anterior Cruciate Ligament Reconstruction Comparing Hamstring Autograft with Bone-Patellar Tendon-Bone Autograft : Why Are They Different? by POOLMAN, Rudolf W, ABOUALI, Jihad A. K, CONTER, Henry J, BHANDARI, Mohit

“…Systematic reviews published on the same topic during a similar period of time (i.e., overlapping reviews) on anterior cruciate ligament reconstruction…”
Get full text